The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease

The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease

Marc L Decramer,1 Nicola A Hanania,2 Jan O Lötvall,3 Barbara P Yawn41Respiratory Division, University Hospital, KU Leuven, Belgium; 2Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA; 3Krefting Research Centre, University of Gothenburg...

Full description

Bibliographic Details
Main Authors: Decramer ML, Hanania NA, Lötvall JO, Yawn BP
Format: Article
Language:English
Published: Dove Medical Press 2013-01-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/the-safety-of-long-acting-szlig2-agonists-in-the-treatment-of-stable-c-a12070

Internet

http://www.dovepress.com/the-safety-of-long-acting-szlig2-agonists-in-the-treatment-of-stable-c-a12070

Similar Items